The Conscious Fund is a venture capital firm established in 2019 and located in Lewes, Delaware. The firm focuses on investing in early-stage companies within the psychedelics medicine sector, particularly those that emphasize plant-powered therapeutic solutions. By targeting innovative ventures in this emerging field, The Conscious Fund aims to support the development of sustainable and effective treatments that leverage the potential of psychedelics for mental health and wellness.
KEIPhone is a company focused on increasing connectivity in sub-Saharan Africa by providing free smartphones and data to the estimated 70% of the population that currently lacks access to the internet. It aims to bridge the digital divide, particularly addressing the gender gap in internet access, by offering smartphones and solar chargers. The company's innovative business model generates revenue through lock screen advertising, which allows users to access content in their local languages via various formats such as video, IVR, web, and SMS. This approach not only enables women to connect and empower themselves but also facilitates the collection of detailed client data for targeted advertising, ultimately improving the lives of its users.
Maya Health
Seed Round in 2021
Naitur.ai is a company focused on enhancing psychedelic healthcare through a specialized practice management platform. Founded in 2019 and based in Denver, Colorado, the platform allows practitioners to track, manage, and measure health outcomes effectively. It offers personalized protocols and psychedelic-specific assessments that help in monitoring dosages, wellness outcomes, and psychological metrics. By streamlining these processes, Naitur.ai aims to reduce the workload for psychedelic practitioners, enabling them to serve a larger number of clients and improve mental health and well-being in the communities they support.
MycroDose Therapeutics
Seed Round in 2021
MycroDose Therapeutics is a U.S.-based pharmaceutical company focused on developing advanced drug delivery systems that utilize psychedelic compounds for the treatment of mental health disorders and cognitive degenerative diseases. The company is actively working on two of its four core technologies, which include a psilocybin transdermal delivery system and a ketamine oral mucosa delivery system. By leveraging these innovative approaches, MycroDose Therapeutics aims to enhance the efficacy and accessibility of treatments for patients dealing with these challenging conditions.
HIVE BIO
Seed Round in 2021
We develop next-generation mental health care protocols and the tools needed to deliver safer access to life-changing therapies for the millions who need them. We are opening a network of residential clinics using psychedelic-assisted psychotherapy.
WeSana Health
Convertible Note in 2021
WeSana Health is a life sciences company focused on the advancement of psilocybin-based medicine. Founded in 2020 by Daniel Carcillo, the company is headquartered in Homer Glen, Illinois. WeSana Health is actively exploring new business opportunities to further its mission in the burgeoning field of psychedelics, aiming to develop innovative therapeutic solutions for various mental health conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.